Although SIRPB1’s functions were initially identified outside of oncological settings, new research highlights the critical role it plays in the glioma immunological landscape, especially when it comes to spleen tyrosine kinase (SYK) [9]. This evidence concerns the gene SIRPB1 and central nervous system cancer.